advisorsecurities master

MGTXMeiraGTx Holdings plc Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key
18536
Ticker
MGTX
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2018-06-08
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MGTX

Detail

Enriched 2026-08-14 20:47

Market cap
$1,200,219,327.36
Shares outstanding (class)
92,609,516
Shares outstanding (weighted)
92,609,516
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
409
Location
NEW YORK, NY
Description

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data